Novel heterozygous mutation in TBX1 in an infant with hypocalcemic seizures
暂无分享,去创建一个
[1] S. Eliez,et al. 22q11.2 deletion syndrome , 2019, Nature Reviews Disease Primers.
[2] Ruo-Gu Li,et al. A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease , 2015, Pediatric Cardiology.
[3] Jonathan H. Chung,et al. Mouse and human CRKL is dosage sensitive for cardiac outflow tract formation. , 2015, American journal of human genetics.
[4] N. de Leeuw,et al. Central 22q11.2 deletions , 2014, American journal of medical genetics. Part A.
[5] K. Nakayama,et al. TBX1 Mutation Identified by Exome Sequencing in a Japanese Family with 22q11.2 Deletion Syndrome-Like Craniofacial Features and Hypocalcemia , 2014, PloS one.
[6] Y. Moreau,et al. Congenital heart defects in a novel recurrent 22q11.2 deletion harboring the genes CRKL and MAPK1 , 2012, American journal of medical genetics. Part A.
[7] H. Sticht,et al. Human TBX1 missense mutations cause gain of function resulting in the same phenotype as 22q11.2 deletions. , 2007, American journal of human genetics.
[8] Joe C. Adams,et al. Full spectrum of malformations in velo-cardio-facial syndrome/DiGeorge syndrome mouse models by altering Tbx1 dosage. , 2004, Human molecular genetics.
[9] S. Minoshima,et al. Role of TBX1 in human del22q11.2 syndrome , 2003, The Lancet.
[10] E. Zackai,et al. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects , 2001, Journal of medical genetics.
[11] V. Papaioannou,et al. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1 , 2001, Nature Genetics.
[12] P. Scambler,et al. Tbx1 haploinsufficiency in the DiGeorge syndrome region causes aortic arch defects in mice , 2001, Nature.
[13] Birgit Funke,et al. TBX1 Is Responsible for Cardiovascular Defects in Velo-Cardio-Facial/DiGeorge Syndrome , 2001, Cell.
[14] E. Zackai,et al. Skeletal anomalies and deformities in patients with deletions of 22q11. , 1997, American journal of medical genetics.